Years-long delays to access ‘life-changing’ diabetes technology

12 Mar 2025

One News

Last August, the drug-buying agency announced that CGMs and insulin pumps would be made universally available for people with type 1 diabetes. However, many have told 1News that while the CGMs are easy to access, they will have to wait up to five years before they can receive an insulin pump.

Health NZ Te Whatu Ora confirmed that the delays in the rollout of insulin pumps are due to significant staff shortages, with some clinicians estimating the country has only about half the number of specialists required to meet international standards.

Read more

Other stories

Academic LiteratureDrugs, devices and diagnostics
Cover Health Policy Journal
The development of a discrete choice experiment: Investigating pharmacy selection in New Zealand

The development of a discrete choice experiment: Investigating pharmacy selection in New Zealand

Discrete choice experiments (DCEs) provide a method for understanding preferences for service provision and there have been limited applications to the selection of community pharmacies. The validity and accuracy of DCEs rely upon the attributes and levels used. This paper aims to describe the development of a DCE investigating New Zealanders preferences for community pharmacies.

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.